CCL2 was a highly expressed cytokine in HNSCC cells under the serum-deficient condition (Fig. 1A, B), indicating that tumor cells were an important cellular source of CCL2 in the tumor microenvironment. This evidence concerns the gene CCL2 and head and neck squamous cell carcinoma.